NEW YORK, Jan. 17, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Fenix Parts, Inc. (NASDAQ:FENX) securities between May 14, 2015 and October 12, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/fenix-parts-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Fenix had an inadequate inventory valuation methodology; (2) Fenix had an inadequate methodology to calculate goodwill impairment; (3) Fenix was engaging and/or had engaged in conduct that would result in an SEC investigation; and (4) as a result, Defendants’ statements about Fenix’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Fenix Parts you have until March 13, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/fenix-parts-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Italy Fines Apple €98.6 Million Over App Store Dominance
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 



